Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Possible Path Toward First Anti-MERS Drugs

28.07.2015

Researchers at the NIH's National Cancer Institute determine three crystal structures that could act as a structural basis for a novel MERS inhibitor

If you haven't heard of Middle East Respiratory Syndrome, thank geography, NGOs, and government agencies like the Centers for Disease Control and Prevention and the World Health Organization (WHO) for keeping the new disease in check. In camels, which act as a reservoir for the causative coronavirus, the illness causes a runny nose; in humans, it causes a cough, fever, and, in 36 percent of cases, death, according to the WHO.


Credit: Needle, D., G.T. Lountos, and D.S. Waugh/Acta Crystallogr D Biol Crystallogr

Crystallographic snapshot at 1.55 Angstroms resolution of the interaction between the MES 3CLpro homodimer (gray and green surfaces) and the C-terminal tail of a neighboring 3CLpro molecule (red) in the crystal lattice.

The virus has recently spread to South Korea, but the first cases were reported in Saudi Arabia in 2012. Vaccinating camels has been proposed as a solution, but a suitable animal vaccine has yet to be developed, and there are currently no drug treatments available for the virus.

This week at the American Crystallographic Association (ACA) 2015 Meeting in Philadelphia, researchers from the National Cancer Institute will present three newly determined crystal structures, which collectively provide a starting point for structure-based drug design efforts to combat MERS. The work will be presented by George Lountos, a scientist in the lab of primary investigator David Waugh.

MERS-CoV is part of the betacoronavirus genus, whose infamous cousins include the viruses responsible for SARS and the common cold. As a positive-sense species, its viral RNA is laid out in the 5' to 3' direction of RNA translation, allowing it to skip transcription to messenger RNA and be directly translated into proteins.

When the virus initiates replication, its genome gets translated into two large polyprotein chains, which are then cleaved into smaller functional proteins by enzymes called proteases. At the 5' end, a long open reading frame encodes for 16 non-structural proteins, one of which is the 3C-like protease, or 3CLpro. Once active, 3CLpro cleaves the other non-structural proteins to form mature proteins that are involved in viral replication. By blocking its activity, you can completely shut the process down.

Inhibiting viral replication by blocking proteases is a tried and true method of treating infections and has been proven to save lives of people with other types of viral infections, like HIV.

Using X-ray crystallography, the researchers determined three crystal structures of a catalytically inactive variant, C148A, of 3CLpro - one of the free enzyme, and two representing enzyme-product complexes.

To find suitable drug development candidates, the researchers intend to use fragment-based screening, in which low weight molecular compounds with weak affinities for the protease are soaked into its crystallized protein form. The fragments are typically lighter than 250 Daltons -- for comparison, a caffeine molecule weighs 194 Daltons -- and are selected in advance for favorable drug-like properties and amenability to further chemical modifications. Structural information gleaned from the fragments bound to the 3CLpro can then be used to optimize the fragments into higher affinity inhibitors.

Drug design efforts from other laboratories have focused on peptidomimetics, small protein-like chains that mimic peptides. While these are easily synthesized, they are not easily administered orally, which limits their appeal as antivirals.

Additionally, the researchers have identified an enzyme-product complex within their current crystal structures. When crystallized, the enzyme forms homodimers, or molecules composed of paired identical proteins. The 3CLpro can cleave itself from the long polyprotein chain by recognizing cleavage site sequences that flank it, which resulted in the discovery of a 3CLpro molecule bound to the 3CLpro homodimer active site via its autoprocessed C-terminal tail in the crystal lattice. This gives the researchers a snapshot of how the 3CL-protease can recognize the cleavage site of an unprocessed protein chain, and thus crucial information about which areas of the enzyme's active site they need to target to block the interaction.

Lountos and his colleagues have recently begun working through their library of compounds, and they estimate it will take at least a year to sort through the data from the bound fragments and find a lead compound, upon which further biochemistry studies will then need to be done before the longer process of drug design can begin.

Poster M24, "Structures of the Middle East Respiratory Syndrome Coronavirus 3C-Like Protease, an Anti-Viral Drug Target," by George Lountos, David S. Waugh and Danielle Needle will be available on Monday, July 27th, beginning at 11:00 AM, with authors present for discussion from 5:30-7:30 PM, in the Liberty Ballroom at the Sheraton Downtown Hotel.

###

MORE ABOUT THE MEETING

More than 700 professionals and students from more than 20 countries and from diverse areas across industry and academia are expected to attend the American Crystallographic Association (ACA) 65th annual meeting in Philadelphia, from July 25-29, the largest crystallography conference of the year in the United States.

All scientific sessions, workshops, poster sessions, and events will be held at the Sheraton Philadelphia Downtown Hotel. To obtain more information or free registration for press, please contact Jason Socrates Bardi at: 240-535-4954 or jbardi@aip.org

USEFUL LINKS

Main meeting website: http://www.amercrystalassn.org/2015-mtg-homepage
Scientific program: http://www.amercrystalassn.org/2015-scientific-program
Hotel: http://www.sheratonphiladelphiadowntown.com
Twitter: #ACAPhilly

ABOUT THE SCIENCE OF CRYSTALLOGRAPHY

Crystallography is a field that lies at the crossroads of biology, chemistry, physics and materials science. Researchers from areas as far flung as genomics, geology, medicine and manufacturing use it to uncover the exact arrangements of atoms within molecules and bulk materials -- information of keen interest to modern science because it helps to define the real-life chemical and physical properties of materials. The structures uncovered by crystallography are also of profound importance to humanity because they are routinely used to guide the creation of new lifesaving drugs, improve manufacturing processes and make new materials that impact our economy and our world.

ABOUT ACA

The American Crystallographic Association (ACA) was founded in 1949 through a merger of the American Society for X-Ray and Electron Diffraction (ASXRED) and the Crystallographic Society of America (CSA). The objective of the ACA is to promote interactions among scientists who study the structure of matter at atomic (or near atomic) resolution. These interactions will advance experimental and computational aspects of crystallography and diffraction. They will also promote the study of the arrangements of atoms and molecules in matter and the nature of the forces that both control and result from them. See: http://www.amercrystalassn.org

Contact Information
Jason Socrates Bardi
+1 240-535-4954
jbardi@aip.org
@jasonbardi

Jason Socrates Bardi | newswise

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>